For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Buscar Close Search

Print

2023 RESEARCH

- Archives -

UMass Chan researchers achieve gene therapy milestone for potential Cockayne syndrome treatment

UMass Chan researchers achieve gene therapy milestone for potential Cockayne syndrome treatment

Researchers working with UMass Chan Medical School’s Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare and fatal neurodegenerative disease that largely affects children and young adults.

Small pilot study explores addition of remote activity tracking to electronic health records

Small pilot study explores addition of remote activity tracking to electronic health records

The pilot project aims to determine if wearable devices can help the flow of patient data to electronic health records and give providers the opportunity to assist patients more effectively with weight management.

Trio of UMass Chan researchers receive awards for studies on age-related macular degeneration

Trio of UMass Chan researchers receive awards for studies on age-related macular degeneration

Claudio Punzo, PhD; Johanna Seddon, MD, ScM; and Shun-Yun Cheng, PhD’22, are receiving awards from the American Macular Degeneration Foundation.

UMass Chan neurobiologist Eviatar Yemini recognized with Hypothesis Fund award

UMass Chan neurobiologist Eviatar Yemini recognized with Hypothesis Fund award

Eviatar Yemini, PhD, was chosen to receive a seed grant from the Hypothesis Fund, an innovative, new nonprofit that relies on a network of scientist “scouts” to identify and recommend novel, early-stage research to fund.

UMass Chan researchers contribute to study of drug prevalence among injured road users

UMass Chan researchers contribute to study of drug prevalence among injured road users

Kavita Babu, MD, was a co-author of a recent study from the National Highway Traffic Safety Administration on toxicological analyses of blood specimens from roadway users who were seriously or fatally injured in motor vehicle crashes.

Susan Swain receives grant to explore harnessing B cells for a universal flu vaccine for older adults

Susan Swain receives grant to explore harnessing B cells for a universal flu vaccine for older adults

The goal of research by Susan Swain, PhD, is to ultimately provide a blueprint for a vaccine that would recognize evolving influenza strains and provide long-lasting immunity to people throughout the life cycle, particularly among older adults, whose immune responses become weaker as they age.

UMass Chan licenses rights to spinal muscular atrophy gene therapy program to CANbridge Pharmaceuticals

UMass Chan licenses rights to spinal muscular atrophy gene therapy program to CANbridge Pharmaceuticals

UMass Chan Medical School has licensed the rights to develop and commercialize a novel second-generation gene therapy to treat spinal muscular atrophy developed by Jun Xie, PhD, Guangping Gao, PhD, and colleagues to global biopharmaceutical company CANbridge Pharmaceuticals Inc.

UMass Chan to participate in pilot COVID-19 telehealth program Home Test to Treat launched by NIH

UMass Chan to participate in pilot COVID-19 telehealth program Home Test to Treat launched by NIH

UMass Chan Medical School will evaluate the NIH’s new Home Test to Treat program that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities across the country.